|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Aastrom Biosciences, Inc. (ASTM) to Participate in Noble Financial Capital Markets' BioX Life Sciences Exposition
9/19/2012 9:25:08 AM
ANN ARBOR, Mich., Sept. 19, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will participate in the Advancements in Cell Therapy & Regenerative Medicine discussion at the Noble Financial Capital Markets' BioX Life Sciences Exposition. The discussion will take place on Monday, September 24, 2012 at 11:45 a.m. at the University of Connecticut, Stamford Campus.
|
|
|
|
|
|
|
|
|
|
|